An extraordinary brand launch
QUANTA Dialysis Technologies is a British medical technology innovation company, whose flagship personal haemodialysis system SC+, was commercialised in 2020, after 10 years’ development and both CE certification and FDA approval for commercialisation in the UK and USA.
As it turned out, the first shipment of new SC+ devices went straight to ICU wards across the UK to help deal with emergency kidney failure patients at the start of the COVID-19 pandemic.
For the previous year, we had been working with the senior team to reposition and redefine the QUANTA corporate brand strategy, in readiness for international growth and commercial expansion. Through internal and external stakeholder research we evolved and validated a new articulation for the brand focused on Quanta’s drive to enable people’s lives, which led to a new brand Purpose: To Improve Dialysis Experiences and Help People Live More Freely.